2008 Second Quarter in Review
Well. That wasn't pleasant. The market (as measured by the S&P500)extended its losses for the year, down about 3% for Q208. We are now at128...

Renhuang Wins Key Laboratory Designation
Renhuang Pharmaceuticals, Inc. (RHGP.OB) reported that its wholly-owned Traditional Chinese Medicine Extract and Innovation Laboratory was r...

Is 3SBio Too Conservative to Move Forward?
In February 2007, the IPO from 3SBio (NSDQ: SSRX) made a big splash on Nasdaq. It was the first of the major China biopharma IPOs, and it wa...

China's Negative Economic Outlook
Certain recent developments in conjunction with prevailing global economic trends appear sufficiently serious to warrant a current economic ...

Chinese Tech Stock Weekly Summary (6/23 - 6/29)
The following is excerpted from IRG's weekly stock report: ...

China Security & Surveillance: One To Watch Closely
On the heels of a follow-up report by the Security Industry Association (which very conservatively projects Chinese security industry spendi...

Tongjitang Slides After Buyout Offer Withdrawn
Tongjitang Chinese Medicines Company (NYSE: TCM) reported that the offer to buy the company has been withdrawn. The offer was made by Tongji...